Cargando…

Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteins

Along with the nasal epithelium, the lung epithelium is a portal of entry for sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and many other respiratory viruses. In the case of SARS-CoV-2, the virus surface spike proteins bind to the angiotensin-converting enzyme 2 (ACE-2) receptor to f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Daniel P., Osborn, Mark J., Steer, Clifford J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Full-Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367755/ https://www.ncbi.nlm.nih.gov/pubmed/34551876 http://dx.doi.org/10.1016/j.jcyt.2021.07.017

Ejemplares similares

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Directed evolution of angiotensin‐converting enzyme 2 peptidase activity profiles for therapeutic applications
por: Heinzelman, Pete, et al.
Publicado: (2023)

A Hydrophobic‐Interaction‐Based Mechanism Triggers Docking between the SARS‐CoV‐2 Spike and Angiotensin‐Converting Enzyme 2
por: Li, Jiacheng, et al.
Publicado: (2020)

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
por: Ho, Tin-Yun, et al.
Publicado: (2007)

Decoding molecular factors shaping human angiotensin converting enzyme 2 receptor usage by spike glycoprotein in lineage B beta-coronaviruses
por: Chakraborty, Sandipan, et al.
Publicado: (2022)

An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension
por: Fuchs, Elisabeth, et al.
Publicado: (2022)

Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
por: Collins, Daniel P, et al.
Publicado: (2021)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition
por: Di Rienzo, Lorenzo, et al.
Publicado: (2021)

Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2
por: Mathewson, Alison C., et al.
Publicado: (2008)

An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade
por: Han, Songling, et al.
Publicado: (2021)

In vitro Differentiation of Human TERT-Transfected Multi-Lineage Progenitor Cells (MLPC) into Immortalized Hepatocyte-Like Cells
por: Collins, Daniel P, et al.
Publicado: (2020)

Development of immortalized human hepatocyte-like hybrid cells by fusion of multi-lineage progenitor cells with primary hepatocytes
por: Collins, Daniel P., et al.
Publicado: (2020)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
por: Jafary, Farzaneh, et al.
Publicado: (2021)

SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
por: Matthews, Alicia M., et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Regulation of Angiotensin Converting Enzyme 2 and Tissue Renin-Angiotensin Systems: Influence of Biologic Sex
por: Ensor, Charles M., et al.
Publicado: (2021)

Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
por: Du, Jianbin, et al.
Publicado: (2022)

Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS‐CoV‐2
por: Planchais, Cyril, et al.
Publicado: (2022)

Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
por: Hati, Sanchita, et al.
Publicado: (2020)

Angiotensin-converting Enzyme 2–containing Small Extracellular Vesicles and Exomeres Bind the Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Zhang, Qin, et al.
Publicado: (2021)

Uptake of severe acute respiratory syndrome coronavirus 2 spike protein mediated by angiotensin converting enzyme 2 and ganglioside in human cerebrovascular cells
por: McQuaid, Conor, et al.
Publicado: (2023)

Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains
por: Canhui Cao, et al.
Publicado: (2020)

Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex
por: Laurini, Erik, et al.
Publicado: (2020)

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020)

Indigo plant leaf extract inhibits the binding of SARS-CoV-2 spike protein to angiotensin-converting enzyme 2
por: Hagiyama, Man, et al.
Publicado: (2022)

FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
por: Miller, Christina J., et al.
Publicado: (2021)

Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant
por: Jawad, Bahaa, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence
por: Laurini, Erik, et al.
Publicado: (2021)

Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
por: Lupala, Cecylia Severin, et al.
Publicado: (2022)

Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2
por: Takaoka, Yutaka, et al.
Publicado: (2022)

Multiple sites on SARS‐CoV‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V
por: Bollavaram, Keval, et al.
Publicado: (2021)

Engineering defensin α‐helix to produce high‐affinity SARS‐CoV‐2 spike protein binding ligands
por: Fernandes, Leonardo Antônio, et al.
Publicado: (2022)

Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2021)

Timing matters: Impact of anticonvulsant drug treatment and spikes on seizure risk in benign epilepsy with centrotemporal spikes
por: Xie, Wenting, et al.
Publicado: (2018)

Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19
por: Toor, Himanshu G., et al.
Publicado: (2021)

Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants
por: Dobrynin, Daniela, et al.
Publicado: (2022)

Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish
por: Kraus, Aurora, et al.
Publicado: (2022)

An ultra-sensitive electrochemical biosensor using the Spike protein for capturing antibodies against SARS-CoV-2 in point-of-care
por: Cardoso, Ana R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvve1e44n3dcffvh1hpkvuocrj